Objective:

To visualize lipid metabolism at the single-cell level during drug-induced apoptosis, emphasizing its significance for understanding cellular responses.

Key Findings:

• Apoptosis is accompanied by coordinated metabolic shifts, with structural phospholipids declining and energy-storage lipids mobilizing, highlighting the dynamic nature of lipid metabolism.
• Distinct 'lipid fingerprints' were produced by different drugs, indicating their unique mechanisms of action and potential for targeted therapies.
• Marked variability in lipid responses was observed among individual cells within the same population, suggesting the need for personalized approaches in treatment.

Interpretation:

The findings suggest that lipid metabolism is intricately linked to cellular responses during drug-induced apoptosis, highlighting the potential of the MSI platform for precision medicine and future research.

Limitations:

• The study primarily focused on two cell lines (HeLa and HepG2), which may limit the generalizability of the findings; further validation in diverse cell types and in vivo models is necessary.
• Further studies are needed to explore the implications of the observed lipid remodeling in different contexts.

Conclusion:

The MSI platform offers a powerful tool for linking metabolic changes to cellular phenotypes, potentially aiding drug development and precision medicine by providing insights at the single-cell level.